Female infertility. Female infertility, unspecified
Conditions
Interventions
30ml (300 mgr/ml) GCSF was administered by slow Trans-cervical intrauterine infusion in intervention group..
Treatment - Drugs
30ml (300 mgr/ml) GCSF was administered by slow Trans-cervical intrauterine infusion in intervention group.
Sponsors
Research and Clinical Center for Infertility, Vice Chancellor for research, Shahid Sadoughi Universi
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Infertile women between 20-45 years old referred to Yazd infertility center, history of at least 2 implantation failure. Exclusion criteria: Participants with sickle cell disease, chronic neutropenia, history of malignancy, renal failure, congenital fructose intolerance, respiratory infection, endometriosis and sever male factor
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 2 weeks after. Method of measurement: Emberyo transfer.;Clinical pregnancy. Timepoint: 2-3 weeks after positive pregnancy test. Method of measurement: gestational sac and fetal heart on ultrasound examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| -. Timepoint: -. Method of measurement: -. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam Eftekhar
Research and Clinical Center for Infertility, School of Medicine, Shahid Sadoughi University of Medi
Outcome results
None listed